NSAIDs and gastrointestinal complications: new clinical challenges (Q36326243)

13 August 2017

1 reference

title

NSAIDs and gastrointestinal complications: new clinical challenges (English)

1 reference

13 August 2017

Neena S Abraham

1

1 reference

13 August 2017

David Y Graham

series ordinal

2

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

Expert Opinion on Pharmacotherapy

13 August 2017

published in

1 reference

13 August 2017

volume

6

1 reference

13 August 2017

issue

15

1 reference

13 August 2017

page(s)

2681-2689

1 reference

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

Excess costs from gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

Gastrointestinal health care resource utilization with chronic use of COX-2-specific inhibitors versus traditional NSAIDs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

Nonselective nonaspirin nonsteroidal anti-inflammatory drugs and gastrointestinal bleeding: relative and absolute risk estimates from recent epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

Risks of clinically significant upper gastrointestinal events with etodolac and naproxen: a historical cohort analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

NSAIDs, Helicobacter pylori, and Pandora's Box.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

Over-the-counter pain reliever and aspirin use within a sample of long-term cyclooxygenase 2 users

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

A randomized, controlled comparison of ibuprofen at the maximal over-the-counter dose compared with prescription-dose celecoxib on upper gastrointestinal mucosal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

Merck withdraws arthritis drug worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

Nonsteroidal antiinflammatory drugs and dyspepsia in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

Risk of uncomplicated peptic ulcer among users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

Non-steroidal anti-inflammatory drugs and ulcer complications: a risk factor analysis for clinical decision-making.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.15.2681

10.1517/14656566.6.15.2681

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference